Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00294203 · ClinicalTrials.gov registry record · Phase 1
Pilot Study of Epoetin Alfa for Patients Having Abdominal or Pelvic Surgery for Cancer
A Phase 1 study, sponsored by University of Florida.
- Completed
- Registry status
- Phase 1
- Development phase
- 40
- Enrollment target
NCT00294203 is a Phase 1 study that has completed, run by University of Florida. The registered enrollment target is 40 participants.
The verdict
NCT00294203, a Phase 1 study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 40 participants
- Enrollment target
Study Summary
This pilot study is looking at how well epoetin alfa, given in the immediate post-operative period, works in reducing anemia and the need for transfusions.
Interventions
- OTHER Placebo group
- DRUG Epoetin Alfa group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2006-02 |
| Est. Completion | 2008-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00294203
The ClinicalTrials.gov registry entry for NCT00294203 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo group is the first listed.
NCT00294203 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00294203 about?
NCT00294203 is a clinical study titled "Pilot Study of Epoetin Alfa for Patients Having Abdominal or Pelvic Surgery for Cancer". This pilot study is looking at how well epoetin alfa, given in the immediate post-operative period, works in reducing anemia and the need for transfusions.
What is the current status of trial NCT00294203?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2006-02. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00294203?
The interventions under investigation include: Placebo group (OTHER), Epoetin Alfa group (DRUG).
Who is sponsoring clinical trial NCT00294203?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.